cladribine has been researched along with Aplasia Pure Red Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bussutil, DP; Chasty, RC; Copplestone, JA; Hamon, MD; Myint, H; Orchard, JA; Oscier, DG; Prentice, AG | 1 |
| Bloński, JZ; Dmoszyńska, A; Kasznicki, M; Robak, T; Skotnicki, AB | 1 |
2 other study(ies) available for cladribine and Aplasia Pure Red Cell
| Article | Year |
|---|---|
Autoimmune haemolysis in patients with B-CLL treated with chlorodeoxyadenosine (CDA).
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cladribine; Female; Humans; Leukemia, B-Cell; Lymphocyte Count; Male; Middle Aged; Red-Cell Aplasia, Pure | 1998 |
Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine.
Topics: Aged; Cladribine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Red-Cell Aplasia, Pure | 2001 |